semaglutide for hidradenitis suppurativa Semaglutide for weight loss in obese patients - GLP-1Hidradenitis suppurativaReddit semaglutide to standard hidradenitis suppurative therapies Semaglutide for Hidradenitis Suppurativa: Emerging Hope for Chronic Skin Disease

The treatment ofhidradenitis suppurativawith the glucagon like peptide 1 agonist liraglutide Hidradenitis Suppurativa (HS), a chronic inflammatory skin condition, can significantly impact a patient's quality of life. Characterized by painful lumps, abscesses, and scarring, HS often occurs in areas with apocrine sweat glands, such as the armpits, groin, and under the breasts. While the exact cause remains elusive, a strong association exists between obesity and the severity of HS, leading researchers to explore treatments that target both佛历2567年10月1日—Semaglutide appeared to help patients with both weight management and HS symptoms. The reduction in flare frequency and improvements in quality of life were .... In recent years, semaglutide, a GLP-1 receptor agonist, initially developed for diabetes and weight loss, has shown promising results as an adjunctive therapy for hidradenitis suppurativa.Could This Weight Loss Drug Help with HS? - Dermatology

Understanding Semaglutide and its Mechanism

Semaglutide functions by mimicking the action of the naturally occurring hormone glucagon-like peptide-1 (GLP-1). This mechanism offers several benefits:

* Glucose Regulation: It stimulates insulin secretion and suppresses glucagon release, thereby improving glycemic control in individuals with type 2 diabetes.

* Weight Management: GLP-1 agonists slow gastric emptying and increase satiety, contributing to significant weight loss in patients with obesityCould This Weight Loss Drug Help with HS? - Dermatology.

* Anti-inflammatory Effects: Emerging evidence suggests that semaglutide possesses anti-inflammatory properties that may be beneficial in managing chronic inflammatory conditions like hidradenitis suppurativa.作者：C Drumm·2023·被引用次数：4—Semaglutide was titrated to 1mg subcutaneously once weeklywith no reported adverse effects. At 6 weeks, significant improvement in both subjective and objective ... This anti-inflammatory effect independent of weight loss is a key area of ongoing research.

Promising Clinical Outcomes in Hidradenitis Suppurativa

Multiple studies and reports are highlighting the potential of semaglutide in managing hidradenitis suppurativa.Glucagon‐Like Peptide‐1 Receptor Agonists as Adjunctive ... Research indicates that semaglutide can significantly improve outcomes for individuals suffering from this condition, particularly those with obesityCan Semaglutide Help with Hidradenitis Suppurativa? ....

* Reduced Flare-ups: A consistent finding across studies is the reduction in the frequency and severity of HS flares. For example, one report noted that semaglutide was shown to reduce hidradenitis suppurativa flares in patients with obesity.Patient-reported outcomes of glucagon-like peptide-1 ... Another study indicates that semaglutide may reduce hidradenitis suppurativa flare-ups.

* Improved Quality of Life: Patients undergoing semaglutide treatment have reported significant improvements in their overall quality of life.Semaglutide for weight loss in people with obesity as an ... This includes experiencing fewer disease-related flares and a general improvement in well-being, suggesting that semaglutide treatment significantly improved quality of lifePatient-reported outcomes of glucagon-like peptide-1 ....

* Adjunctive Therapy: Semaglutide is often considered as an adjunctive treatment, meaning it is used in conjunction with existing standard therapies for HS. This combination approach has shown enhanced results, with semaglutide to standard hidradenitis suppurative therapies leading to improved outcomes.

* Dosage and Duration: While individual responses may vary, studies indicate effective use at common dosages作者：MIP Posada·2025·被引用次数：6—Impact ofsemaglutideuse in obese and diabetic patients withhidradenitis suppurativa.. For instance, the mean duration of semaglutide treatment was 8作者：MIP Posada·2025·被引用次数：6—Impact ofsemaglutideuse in obese and diabetic patients withhidradenitis suppurativa..2 months, with a mean dose of 0.8 mg once weekly. In some cases, semaglutide was titrated to 1 mg subcutaneously once weekly with no reported adverse effects, leading to significant subjective and objective improvements.3天前—Lima, “Impact ofSemaglutideUse in Obese and Diabetic Patients WithHidradenitis Suppurativa,” Journal of the European Academy of ...

Specific Patient Experiences

Anecdotal evidence also supports the efficacy of semaglutide for hidradenitis suppurativa. Some patients have reported remarkable improvements, with sentiments like, "Mine have been soooooo much better. I've been on it since April and it's helping so much it's insane."

Beyond Weight Loss: The Broader Potential

While semaglutide for weight loss in people with obesity is a well-established indication, its benefits for hidradenitis suppurativa appear to extend beyond simply addressing excess weight.Patient-reported outcomes of glucagon-like peptide-1 ... The drug’s ability to modulate inflammation and potentially impact the underlying disease processes of HS is a critical aspect of its therapeutic value. Studies suggest that semaglutide reduces the severity of flare-ups and improves inflammatory profiles, offering a multi-faceted approach to managing this complex condition.

Exploring Related Treatments and Compounds

The research into GLP-1 agonists for HS is expanding, with other medications in this class also being investigated.Glucagon‐Like Peptide‐1 Receptor Agonists as Adjunctive ... GLP-1 for hidradenitis suppurativa is a growing area of interest, and drugs like Wegovy (another brand of semaglutide) have also shown promiseCan Semaglutide Help with Hidradenitis Suppurativa? What the .... Similarly, Tirzepatide Hidradenitis Suppurativa and Mounjaro hidradenitis suppurativa are areas that may see further research, as are inquiries into The treatment of hidradenitis suppurativa with the glucagon like peptide 1 agonist liraglutide.

Conclusion

The emerging evidence suggests that semaglutide holds significant potential as a therapeutic agent for hidradenitis suppurativa, particularly in individuals who are also managing obesity.佛历2567年9月26日—Patients with obesity and hidradenitis suppurative treated withWegovyexperienced reduced flare-ups and improved quality of life. Ross Law ... By addressing inflammation, reducing flare-ups, and improving quality of life, semaglutide offers a new avenue of hope for patients struggling with this chronic and often debilitating skin condition. Further clinical trials and ongoing research will continue to refine our understanding of its role and optimize its use in the management of Hidradenitis Suppurativa.